Product Name:

NebuSelect™ Recombinant Human LY6G6D, His-tag

Catalog#:

NBL-241221

Description:

NebuSelect™ Recombinant Human LY6G6D, His-tag(Cat#NBL-241221) is expressed in HEK293 with His tag at the C-terminus.It contains Asn20-Ser104.

Species:

Human

Expression System:

HEK293

Molecular Weight: 

The protein has a predicted MW of 10.20 kDa. Due to glycosylation, the protein migrates to 13-15 kDa based on Bis-Tris PAGE result.

Target Name:

LY6G6D

Target Information:

LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy.

Amino Acid Sequence: 

Asn20-Ser104

Purity:

＞95%

Formulation:

see COA

Endotoxin:

＜1EU/ug(LAL Method)

Storage: 

4°C for short term. 

-20°C for long term.

To get more information, please contact us freely.